| Particulars |
|
|
|
| Company Name
| Aurobindo Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
58.08 |
B.V. (₹) |
369.20 |
| Sales(₹ Cr.) |
10,933.30 |
NP (₹ Cr.) |
1,741.31 |
| NP Var% |
-11.00 |
Div% |
0.00 |
| CPS(₹) |
35.10 |
EPS (₹) |
30.00 |
| Traded Value(₹ Lakhs) |
706.39 |
52 Week High |
1,359.00 |
| 52 Week Low |
994.00 |
Price BSE |
1,336.00 |
| Price NSE |
1,334.00 |
Market Capital (₹ Cr.) |
77,592.19 |
| P/C Ratio |
38.10 |
P/E Ratio |
44.60 |
| Price Vs.BV |
3.62 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
2,726.38 |
| NP(₹ Cr.) |
594.94 |
NP Var % |
26.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
10,713.37 |
| OPM |
23.28 |
NP |
2,069.02 |
| NP Var% |
11.80 |
EPS |
36.91 |
| PE |
36.19 |
|
|